Pacira | PCRX - EPS Earnings Per Share


Pacira reported $0.73 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.76 0.70 Oct/29
FY2026Q2 Jun/2026 0.73 0.65 0.74 Aug/04
FY2026Q1 Mar/2026 0.60 0.73 0.62 Apr/30
FY2025Q4 Dec/2025 0.91 0.91 Feb/26
FY2025Q3 Sep/2025 0.70 0.66 0.79 Nov/06




Eps Change Date
Astellas Pharma JPY 79.15 54.86 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Cara Therapeutics USD -0.72 0.14 Mar/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ironwood Pharmaceuticals USD 0.31 0.07 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Ligand Pharmaceuticals USD 2.37 0.74 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.73 0.13 Jun/2026
Perrigo USD 0.5 0.07 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Supernus Pharmaceuticals USD -1.01 1.61 Jun/2026
Teva Pharmaceutical Industries USD 0.06 1.51 Jun/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026
Zoetis USD 1.87 0.34 Jun/2026